Filing Details
- Accession Number:
- 0001193805-25-000885
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-16 17:00:19
- Reporting Period:
- 2025-06-13
- Filing Date:
- 2025-06-16
- Accepted Time:
- 2025-06-16 17:00:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1280776 | Immunic Inc. | IMUX | Pharmaceutical Preparations (2834) | 562358443 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1591098 | Duane Nash | 1200 Avenue Of The Americas, Suite 200 New York NY 10036 | Executive Chairman | Yes | Yes | No | No |
Transaction Summary
Purchased: | 20,000 shares | Avg. Price: $0.83 | Total Value: $16,694.00 |
Number of Shares After Transactions: | 36,032 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-06-13 | 20,000 | $0.83 | 36,032 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.83 to $0.84. The Reporting Person (RP) undertakes to provide to the Issuer, any securityholder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.